The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study Seite 1
25.10.2023 - – Daily administration for 60 days was well-tolerated with no treatment-related adverse events – – Preclinical data support the safety and tolerability of RaniPill capsule for subsequent clinical studies – SAN JOSE, Calif., Oct. 25, 2023 ... Seite 1